Brief: Quince Therapeutics Details Strategic Growth Plan With Launch Of New Corporate Name

IRulya Therapeutics

01/08/2022 13:09

Aug 1 (Reuters) - 
    * QUINCE THERAPEUTICS DETAILS STRATEGIC GROWTH PLAN WITH
LAUNCH OF
NEW CORPORATE NAME
    * CORTEXYME INC - STRONG CASH POSITION OF APPROXIMATELY $105
MILLION PROVIDES OPERATING RUNWAY INTO SECOND HALF OF 2025
    * CORTEXYME INC - TRADING ON NASDAQ TO INITIATE UNDER NEW
TICKER
SYMBOL "QNCX"

Source text for Eikon:  ID:nBw9LPSdwa 
Further company coverage: [ ]

 ((reuters.briefs@thomsonreuters.com;))